Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Guillain-BarrÉ Syndrome After Immunization in Canadian Children (1996-2012).

Top KA, Desai S, Moore D, Law BJ, Vaudry W, Halperin SA, Bettinger JA; Canadian Immunization Monitoring Program Active.

Pediatr Infect Dis J. 2015 Dec;34(12):1411-3. doi: 10.1097/INF.0000000000000903.

PMID:
26379167
2.

Parents' and adolescents' willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay-Lac-St-Jean (Quebec).

Dubé E, Gagnon D, Hamel D, Belley S, Gagné H, Boulianne N, Landry M, Bettinger JA.

Can J Infect Dis Med Microbiol. 2015 May-Jun;26(3):163-7.

3.

Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012.

Bettinger JA, Rouleau I, Gariepy MC, Bowie WR, Valiquette L, Vanderkooi OG, Kellner JD, Coleman BL, McNeil SA, McCarthy A, De Serres G; Public Health Agency of Canada/Canadian Institutes for Health Research Influenza Research Network.

Euro Surveill. 2015 Jul 23;20(29):21189.

4.

Examining Perceptions about Mandatory Influenza Vaccination of Healthcare Workers through Online Comments on News Stories.

Lei Y, Pereira JA, Quach S, Bettinger JA, Kwong JC, Corace K, Garber G, Feinberg Y, Guay M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Program Delivery and Evaluation Group.

PLoS One. 2015 Jun 18;10(6):e0129993. doi: 10.1371/journal.pone.0129993. eCollection 2015.

5.

Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study.

Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA; investigators of the Canadian Immunization Monitoring Program, ACTive (IMPACT).

Clin Infect Dis. 2015 Apr 15;60(8):e27-35. doi: 10.1093/cid/civ028. Epub 2015 Jan 20.

PMID:
25605282
6.

Evolving meningococcal immunization strategies.

Sáfadi MA, Bettinger JA, Maturana GM, Enwere G, Borrow R; Global Meningococcal Initiative.

Expert Rev Vaccines. 2015 Apr;14(4):505-17. doi: 10.1586/14760584.2015.979799. Epub 2014 Dec 10. Review.

PMID:
25494168
7.

Rapid online identification of adverse events after influenza immunization in children by PCIRN's National Ambulatory Network.

Bettinger JA, Vanderkooi OG, MacDonald J, Kellner JD.

Pediatr Infect Dis J. 2014 Oct;33(10):1060-4. doi: 10.1097/INF.0000000000000373.

PMID:
25361187
8.

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.

Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA; investigators of the Canadian Immunization Monitoring Program, ACTive (IMPACT).

Clin Infect Dis. 2014 Nov 1;59(9):1208-15. doi: 10.1093/cid/ciu597. Epub 2014 Jul 28.

9.

Burden of seasonal influenza in children with neurodevelopmental conditions.

Burton C, Vaudry W, Moore D, Bettinger JA, Tran D, Halperin SA, Scheifele DW; IMPACT investigators.

Pediatr Infect Dis J. 2014 Jul;33(7):710-4. doi: 10.1097/INF.0000000000000272.

PMID:
24918745
10.

Effectiveness of the standard and an alternative set of Streptococcus pneumoniae multi locus sequence typing primers.

Adamiak P, Vanderkooi OG, Kellner JD, Schryvers AB, Bettinger JA, Alcantara J.

BMC Microbiol. 2014 Jun 3;14:143. doi: 10.1186/1471-2180-14-143.

11.

Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation.

Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Scheifele DW, Halperin SA.

BMC Public Health. 2014 May 12;14:442. doi: 10.1186/1471-2458-14-442.

12.

Childhood immunization rates in Canada are too low: UNICEF.

Scheifele DW, Halperin SA, Bettinger JA.

Paediatr Child Health. 2014 May;19(5):237-8. No abstract available.

13.

Home environmental tobacco smoke exposure in Canadian children.

Slogrove AL, Bettinger JA.

Int J Tuberc Lung Dis. 2014 Apr;18(4):499-504. doi: 10.5588/ijtld.13.0648.

PMID:
24670709
14.

How best to describe the risk of meningococcal B infection?

Sadarangani M, Bettinger JA, Scheifele DW.

Paediatr Child Health. 2013 Dec;18(10):543-4. No abstract available.

15.

Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.

Top KA, Constantinescu CM, Laflèche J, Bettinger JA, Scheifele DW, Vaudry W, Halperin SA, Law BJ.

Vaccine. 2013 Nov 19;31(48):5700-5. doi: 10.1016/j.vaccine.2013.09.048. Epub 2013 Oct 5.

PMID:
24099871
16.

Immunizing health care workers against influenza: a glimpse into the challenges with voluntary programs and considerations for mandatory policies.

Quach S, Pereira JA, Kwong JC, Quan S, Crowe L, Guay M, Bettinger JA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Theme Group.

Am J Infect Control. 2013 Nov;41(11):1017-23. doi: 10.1016/j.ajic.2013.05.016. Epub 2013 Aug 21.

PMID:
23973425
17.

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.

Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, Li Y, Montomoli E, Schneeberg A, Bettinger JA, Halperin SA; PHAC /CIHR Influenza Research Network.

Hum Vaccin Immunother. 2013 Nov;9(11):2460-73. Epub 2013 Jul 9.

18.

Cost effectiveness of infant vaccination for rotavirus in Canada.

Coyle D, Coyle K, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW, Le Saux N.

Can J Infect Dis Med Microbiol. 2012 Summer;23(2):71-7.

19.

Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.

Al-Dabbagh M, Lapphra K, Scheifele DW, Halperin SA, Langley JM, Cho P, Kollmann TR, Li Y, De Serres G, Fortuno ES 3rd, Bettinger JA.

Clin Vaccine Immunol. 2013 Aug;20(8):1108-14. doi: 10.1128/CVI.00659-12. Epub 2013 May 22.

20.

Controlling serogroup B invasive meningococcal disease: the Canadian perspective.

Bettinger JA, Deeks SL, Halperin SA, Tsang R, Scheifele DW.

Expert Rev Vaccines. 2013 May;12(5):505-17. doi: 10.1586/erv.13.30. Review.

PMID:
23659299
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk